Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study

NCT03745313 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03745313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03745313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Completed
Start date
February 5, 2019
Completion date
May 13, 2025
Enrollment
65 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation